Global law firm White & Case LLP has expanded its Global Intellectual Property Practice and Global Life Sciences and Healthcare Industry Group with the addition of four leading life sciences trial litigators. The team comprises partners Elizabeth Holland, Nicholas Mitrokostas, William James and Daniel Margolis. Holland joins as Head of the Firm's Global Life Sciences IP Litigation Practice and Mitrokostas joins as Co-Head of the Global Life Sciences and Healthcare Industry Group. The group will operate from their current locations in New York, Washington, DC and Boston.
"Top life sciences companies look to White & Case to lead them through complexity," said the Firm's Chair, Heather McDevitt. "This team of formidable litigators greatly strengthens our ability to navigate clients through this sector's rapid innovation, challenging regulatory environment and strategic investment in R&D. We look forward to their contributions to our Firm."
The broad-based and highly experienced team combines a market-leading skill set in patent litigation, trade secrets and licensing disputes. Having worked together for almost two decades, the group has advised leading Fortune 500 pharmaceutical, biotech and medical device companies on some of the most complex life sciences litigations.
"White & Case has a reputation as a premier destination among life sciences companies," said Elizabeth Holland. "We're delighted to join the Firm's vast global platform and collaborate with our new colleagues to drive impactful client results."
Mitrokostas added: "White & Case's IP and Life Sciences partners are at the forefront of industry innovation. We're excited to serve our clients from its elite global platform."
Yar Chaikovsky, Head of the Firm's Global Intellectual Property Practice, commented: "This team is renowned among the life sciences sector for their trial advocacy. Our IP Practice continues to go from strength to strength, and with this group's arrival, we have a further competitive edge to create successful client outcomes in the market's most high-stakes matters."
This is the seventh high-profile partner group to join White & Case over the past year, as the Firm expands globally in strategic areas of focus. This includes M&A partners Aaron Kenavan and Jamie Palmer (both in Sydney); IP partners David Stone, Karla Hughes and Adrian Dykes (all in London); M&A and Shareholder Engagement partners Richard Brand, Kiran Kadekar, Jaye Kasper and Erica Hogan (all in New York); Litigation partners Jonathan Polkes, Stacy Nettleton and Adam Banks (all in New York); M&A partners Helen Croke, Laura Kayani and Nick Matthew (all in London); and Tax partners Arun Birla and Jiten Tank (both in London).
About Elizabeth Holland
Holland is a market-leading first-chair trial lawyer who represents innovator life sciences companies in their most significant and complex litigations. She has extensive experience serving as lead trial counsel for pharmaceutical, biotech and medical device companies in patent infringement litigations, licensing disputes, arbitrations, IPR proceedings and Federal Circuit appeals, with particular expertise in Hatch-Waxman and BPCIA litigation. She was the Co-Head of Global IP Litigation at her prior firm.
About Nicholas Mitrokostas
Mitrokostas is a first-chair life sciences trial lawyer who represents companies in high-stakes patent, trade secret and licensing disputes, including in the biologics and small molecule space. He has served as lead counsel in patent disputes before federal courts, the PTAB, ITC and in arbitrations. He brings particular expertise representing emerging to multinational companies in late-stage drug development issues relating to patent and regulatory exclusivities. He was the Boston Managing Partner at his prior firm.
About William James
William James is an experienced first-chair trial litigator who represents innovator companies in Hatch-Waxman, biologics and medical device litigations. He has served as lead counsel in biotechnology, small molecule and medical device matters before district courts, the Federal Circuit, the PTAB, in arbitrations and at the ITC.
About Daniel Margolis
Daniel Margolis is an experienced life sciences trial litigator specializing in pharmaceutical, biologic, biotechnology and chemical patent cases. He has successfully represented plaintiffs and defendants in federal courts, before the PTAB and the ITC.
Press contact
For more information please speak to your local media contact.
